NSEAnalysts/Institutional Investor Meet/Con. Call Updates28 Oct 2026 · 28 Oct 2026, 11:44 am

Analysts/Institutional Investor Meet/Con. Call Updates

IPCA Laboratories Limited · IPCALAB

✦ AI SummaryResults

IPCA Laboratories Limited has informed the Exchange about a conference call to discuss Q2FY27 earnings and business update.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

IPCA Laboratories Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

IPCALAB_28102026114427_IpcaConcallIntimation05112026.pdf

pdf

Download →
View document text
THRU ONLINE FILING October 28, 2026 BSE Ltd. National Stock Exchange India Limited, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block-G, Dalal Street Bandra Kurla Complex, Bandra – (East). Mumbai 400 023 Mumbai-400051. Scrip Code – 524494 Scrip Code : IPCALAB Dear Sirs, In accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a Conference Call to discuss the Company’s Q2FY27 earnings and business update will be held on Thursday, 5th November, 2026 from 16:00 hrs (IST). Please find enclosed herewith the conference call / invite details. This is for your information / record. Thanking you. Yours faithfully For Ipca Laboratories Limited Harish P. Kamath Corporate Counsel & Company Secretary ACS 6792 Encl: a/a INVITE FOR Q2FY27 EARNINGS CALL OF IPCA LABORATORIES LTD THURSDAY, 5TH NOVEMBER, 2026 AT 16:00 HRS IST Ipca Laboratories Limited (BSE: 524494, NSE:IPCALAB) will organize a conference call for investors and analysts on Thursday, 5th November, 2026 from 16:00 hrs to 17:00 hrs IST to discuss Q2FY27 earnings and business update. The conference call follows the announcement of the Company’s Q2FY27 unaudited financial results on Thursday, 5th November, 2026. Ipca Laboratories Limited management will be represented by Mr. A K Jain – Managing Director and Mr. Harish Kamath – Corporate Counsel & Company Secretary. The call will be hosted by Dam Capital Advisors Ltd. Details of the conference call are as under: Dial-in numbers Universal Access: +91-22- 6280 1384 +91-22- 7115 8285 (accessible from all networks and countries) Diamond Passcode link: Click Here Please dial-in at least 5-10 minutes prior to the schedule to ensure that you are connected to the call in time. For further information please contact Anusha Kawthankar Nitin Agarwal Ipca Laboratories Limited Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.) Tel : +91-22-6210 6051 Tel: +91-22-42022568 anusha.kawthankar@ipca.com nitin.a@damcapital.in